4//SEC Filing
Ullman Anders 4
Accession 0001104659-25-041404
CIK 0001657312other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 5:18 PM ET
Size
5.9 KB
Accession
0001104659-25-041404
Insider Transaction Report
Form 4
Ullman Anders
Director
Transactions
- Award
Restricted Share Units
2025-04-25+96,000→ 96,000 total→ Ordinary Shares (96,000 underlying)
Footnotes (2)
- [F1]Represents an award of Restricted Share Units ("RSUs") covering American Depositary Shares ("ADSs"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
- [F2]The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001836816
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 5:18 PM ET
- Size
- 5.9 KB